Ziftomenib

ziftomenib · Kura Oncology, Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Ziftomenib, covering 2025-06-04 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]